Fatty Acid Binding Proteins: Potential Chaperones of Cytosolic Drug Transport in the Enterocyte?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pharmaceutical Research

• Publication date

  2011-04-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11095-011-0446-1PMID 21523511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Solubility and permeability measurement and applications in drug discovery.

  2010cited by this paper
• Characterization of lipophilic drug binding to rat intestinal fatty acid binding protein

  2009cited by this paper
• Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice

  2009cited by this paper
• Thermodynamics of lipophilic drug binding to intestinal fatty acid binding protein and permeation across membranes.

  2009cited by this paper
• Structural and functional analysis of fatty acid-binding proteins Published, JLR Papers in Press, November 17, 2008.

  2009cited by this paper
• Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet.

  2009cited by this paper
• Probing the fibrate binding specificity of rat liver fatty acid binding protein.

  2009cited by this paper
• Identification of intracellular carriers for the endocannabinoid anandamide

  2009influential reference
• I-FABP expression alters the intracellular distribution of the BODIPY C16 fatty acid analog

  2009cited by this paper
• A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine.

  2008cited by this paper
• Characterization of the drug binding specificity of rat liver fatty acid binding protein.

  2008cited by this paper
• Intestinal efflux transporters and drug absorption.

  2008cited by this paper
• Midazolam Metabolism in Cytochrome P450 3A Knockout Mice Can Be Attributed to Up-Regulated CYP2C Enzymes

  2008cited by this paper
• Liver Fatty Acid-binding Protein Initiates Budding of Pre-chylomicron Transport Vesicles from Intestinal Endoplasmic Reticulum*

  2007cited by this paper
• Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse Published, JLR Papers in Press, November 18, 2006.

  2007cited by this paper
• Inhibitory effect of docosahexaenoic acid (DHA) on the intestinal metabolism of midazolam: in vitro and in vivo studies in rats.

  2007cited by this paper
• Examination of the role of intestinal fatty acid-binding protein in drug absorption using a parallel artificial membrane permeability assay.

  2007influential reference
• Role of Fatty Acid Binding Proteins and Long Chain Fatty Acids in Modulating Nuclear Receptors and Gene Transcription

  2007cited by this paper
• Adaptations to the loss of intestinal fatty acid binding protein in mice

  2006cited by this paper
• Metabolic Learning in the Intestine: Adaptation to Nutrition and Luminal Factors

  2006cited by this paper
• Effect of intestinal fluid flux on ibuprofen absorption in the rat intestine.

  2006cited by this paper
• An Acute and Coincident Increase in FABP Expression and Lymphatic Lipid and Drug Transport Occurs During Intestinal Infusion of Lipid-Based Drug Formulations to Rats

  2006cited by this paper
• The Interaction of Lipophilic Drugs with Intestinal Fatty Acid-binding Protein*

  2005cited by this paper
• An improved method for the purification of rat liver-type fatty acid binding protein from Escherichia coli.

  2005cited by this paper
• Apical/Basolateral Surface Expression of Drug Transporters and its Role in Vectorial Drug Transport

  2005cited by this paper
• The age-related decline in intestinal lipid uptake is associated with a reduced abundance of fatty acid-binding protein

  2004cited by this paper
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004influential reference
• A Predominant Role of Acyl-CoA:monoacylglycerol Acyltransferase-2 in Dietary Fat Absorption Implicated by Tissue Distribution, Subcellular Localization, and Up-regulation by High Fat Diet*

  2004cited by this paper
• Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes.

  2004cited by this paper
• Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone.

  2004cited by this paper
• Intestinal drug transporters: in vivo function and clinical importance.

  2004cited by this paper
• Intracellular lipid binding proteins of the small intestine

  2004influential reference
• A Kinetic Evaluation of the Absorption, Efflux, and Metabolism of Verapamil in the Autoperfused Rat Jejunum

  2003influential reference
• Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites.

  2003cited by this paper
• In Vivo Modulation of Intestinal CYP3A Metabolism by P-Glycoprotein: Studies Using the Rat Single-Pass Intestinal Perfusion Model

  2003influential reference
• New insights into the fatty acid-binding protein (FABP) family in the small intestine

  2002cited by this paper
• Sterol carrier protein‐2:Not just for cholesterol any more

  2002cited by this paper
• Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.

  2002influential reference
• Differential involvement of peroxisome-proliferator-activated receptors α and δ in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine

  2001cited by this paper
• Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.

  2001cited by this paper
• Theoretical considerations on the in vivo intestinal permeability determination by means of the single pass and recirculating techniques.

  2001influential reference
• An examination of the factors affecting intestinal lymphatic transport of dietary lipids.

  2001cited by this paper
• Evaluation of a single‐pass intestinal‐perfusion method in rat for the prediction of absorption in man

  2001influential reference
• Gut expression and regulation of FAT/CD36: possible role in fatty acid transport in rat enterocytes.

  2001cited by this paper
• The drug efflux-metabolism alliance: biochemical aspects.

  2001cited by this paper
• The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice

  2000cited by this paper
• High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement.

  1999cited by this paper
• Concentration‐ and Region‐dependent Intestinal Permeability of Fluvastatin in the Rat

  1998cited by this paper
• Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.

  1998cited by this paper
• Peroxisome proliferator-activated receptors, orphans with ligands and functions.

  1997cited by this paper
• Fatty acid regulation of fatty acid-binding protein expression in the small intestine.

  1997cited by this paper
• Inhibition of binding to fatty acid binding protein reduces the intracellular transport of fatty acids.

  1996cited by this paper
• Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.

  1996cited by this paper
• Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.

  1996cited by this paper
• Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism

  1996cited by this paper
• Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP).

  1996cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995influential reference
• Dietary fat regulates cellular retinol-binding protein II gene expression in rat jejunum.

  1994cited by this paper
• Expression of intestinal fatty acid binding protein in intestinal epithelial cell lines, hBRIE 380 cells.

  1994cited by this paper
• Transcriptional induction of the fatty acid binding protein gene in mouse liver by bezafibrate

  1993cited by this paper
• Immunochemical quantitation of fatty acid-binding proteins. Tissue distribution of liver and heart FABP types in human and porcine tissues.

  1990cited by this paper
• Independent effects of diet and nutritional status on apoprotein B gene expression in rabbit.

  1988cited by this paper
• The cellular fatty acid binding proteins: aspects of structure, regulation, and function.

  1988cited by this paper
• Absorption of progabide from aqueous solutions in a modified recirculating rat intestinal perfusion system

  1988cited by this paper
• Vascular Perfusion of Rat Small Intestine for Permeation and Metabolism Studies

  1984cited by this paper
• Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport.

  1974cited by this paper

• PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Metabolism in Pregnant Subjects and Fetuses

  2024cites this paper
• Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism

  2024cites this paper
• An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism

  2024cites this paper
• Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein (FABP1) and FABP1 Binding Alters Drug Metabolism

  2024cites this paper
• Impact of Intracellular Lipid Binding Proteins on Endogenous and Xenobiotic Ligand Metabolism and Disposition

  2023influential citation
• Excited-state intermediates in a designer protein encoding a phototrigger caught by an X-ray free-electron laser

  2022cites this paper
• Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics

  2020cites this paper
• Mettl3 Deficiency Sustains Long-Chain Fatty Acid Absorption through Suppressing Traf6-Dependent Inflammation Response

  2019cites this paper
• Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.

  2018cites this paper
• Dietary docosahexaenoic acid supplementation enhances expression of fatty acid‐binding protein 5 at the blood–brain barrier and brain docosahexaenoic acid levels

  2018cites this paper
• Fatty Acid-Binding Protein 5 Mediates the Uptake of Fatty Acids, but not Drugs, Into Human Brain Endothelial Cells.

  2017cites this paper
• Fatty Acid Binding Proteins Expressed at the Human Blood–Brain Barrier Bind Drugs in an Isoform-Specific Manner

  2015cites this paper
• Appendix B References to Analytical Methods for Determination of Ibuprofen in Biological Fluids, Principally Plasma

  2015cites this paper
• The unique ligand binding features of subfamily-II iLBPs with respect to bile salts and related drugs.

  2015cites this paper
• Characterization of two distinct modes of drug binding to human intestinal fatty acid binding protein.

  2014cites this paper
• Intestinal transport as a potential determinant of drug bioavailability.

  2013cites this paper
• Current world literature. Lipid metabolism.

  2012cites this paper
• Fatty Acid Induced Remodeling within the Human Liver Fatty Acid-binding Protein*

  2011cites this paper